Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation

Type I Interferonopathies comprise inherited inflammatory diseases associated with perturbation of the type I IFN response. Use of Janus kinase (JAK) inhibitors has been recently reported as possible tools for treating some of those rare diseases. We describe herein the clinical picture and treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Cattalini, Marco, Galli, Jessica, Zunica, Fiammetta, Ferraro, Rosalba Monica, Carpanelli, Marialuisa, Orcesi, Simona, Palumbo, Giovanni, Pinelli, Lorenzo, Giliani, Silvia, Fazzi, Elisa, Badolato, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578119/
https://www.ncbi.nlm.nih.gov/pubmed/34778129
http://dx.doi.org/10.3389/fped.2021.725868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578119/
https://www.ncbi.nlm.nih.gov/pubmed/34778129
http://dx.doi.org/10.3389/fped.2021.725868

Ejemplares similares